202 related articles for article (PubMed ID: 10421657)
21. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
Lankisch TO; Behrens G; Ehmer U; Möbius U; Rockstroh J; Wehmeier M; Kalthoff S; Freiberg N; Manns MP; Schmidt RE; Strassburg CP
J Hepatol; 2009 May; 50(5):1010-8. PubMed ID: 19303655
[TBL] [Abstract][Full Text] [Related]
22. Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.
Sneitz N; Bakker CT; de Knegt RJ; Halley DJ; Finel M; Bosma PJ
Hum Mutat; 2010 Jan; 31(1):52-9. PubMed ID: 19830808
[TBL] [Abstract][Full Text] [Related]
23. Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1).
Ghosh SS; Lu Y; Lee SW; Wang X; Guha C; Roy-Chowdhury J; Roy-Chowdhury N
Biochem J; 2005 Dec; 392(Pt 3):685-92. PubMed ID: 16171463
[TBL] [Abstract][Full Text] [Related]
24. Persistently increased expression of a 3-methylcholanthrene-inducible phenol uridine diphosphate-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas.
Bock KW; Münzel PA; Röhrdanz E; Schrenk D; Eriksson LC
Cancer Res; 1990 Jun; 50(12):3569-73. PubMed ID: 2111208
[TBL] [Abstract][Full Text] [Related]
25. Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats.
Seppen J; van Til NP; van der Rijt R; Hiralall JK; Kunne C; Elferink RP
Gene Ther; 2006 Apr; 13(8):672-7. PubMed ID: 16267566
[TBL] [Abstract][Full Text] [Related]
26. Effect of chrysin and natural coumarins on UGT1A1 and 1A6 activities in rat and human hepatocytes in primary culture.
Chlouchi A; Girard C; Bonet A; Viollon-Abadie C; Heyd B; Mantion G; Martin H; Richert L
Planta Med; 2007 Jul; 73(8):742-7. PubMed ID: 17599282
[TBL] [Abstract][Full Text] [Related]
27. Disruption of HNF1α binding site causes inherited severe unconjugated hyperbilirubinemia.
van Dijk R; Mayayo-Peralta I; Aronson SJ; Kattentidt-Mouravieva AA; van der Mark VA; de Knegt R; Oruc N; Beuers U; Bosma PJ
J Hepatol; 2015 Dec; 63(6):1525-9. PubMed ID: 26220753
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel mutation in UDP-glucuronosyltransferase (UGT1A1) gene in a child with neonatal unconjugated hyperbilirubinemia.
Minucci A; Canu G; Gentile L; Cimino V; Giardina B; Zuppi C; Capoluongo E
Clin Biochem; 2013 Jan; 46(1-2):170-2. PubMed ID: 23099197
[TBL] [Abstract][Full Text] [Related]
29. Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers.
Yasar U; Greenblatt DJ; Guillemette C; Court MH
J Pharm Pharmacol; 2013 Jun; 65(6):874-83. PubMed ID: 23647681
[TBL] [Abstract][Full Text] [Related]
30. [Mutation analysis of UGT1A1 gene in patients with unconjugated hyperbilirubinemia].
Sun SC; Zhou ZM; Chen QR; Peng YS; Tu CQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):425-8. PubMed ID: 23926009
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of transcriptional expression of human UDP-glucuronosyltransferase 1A1 by dexamethasone.
Kanou M; Usui T; Ueyama H; Sato H; Ohkubo I; Mizutani T
Mol Biol Rep; 2004 Sep; 31(3):151-8. PubMed ID: 15560369
[TBL] [Abstract][Full Text] [Related]
32. Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers.
Smith CM; Faucette SR; Wang H; LeCluyse EL
J Biochem Mol Toxicol; 2005; 19(2):96-108. PubMed ID: 15849716
[TBL] [Abstract][Full Text] [Related]
33. Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1.
Bernard P; Goudonnet H; Artur Y; Desvergne B; Wahli W
Mol Pharmacol; 1999 Sep; 56(3):526-36. PubMed ID: 10462540
[TBL] [Abstract][Full Text] [Related]
34. Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 Cells.
Smith CM; Graham RA; Krol WL; Silver IS; Negishi M; Wang H; Lecluyse EL
J Pharmacol Exp Ther; 2005 Dec; 315(3):1256-64. PubMed ID: 16135700
[TBL] [Abstract][Full Text] [Related]
35. Induction of two UDP-glucuronosyltransferase isoforms sensitive to phenobarbital that are involved in morphine glucuronidation: production of isoform-selective antipeptide antibodies toward UGT1.1r and UGT2B1.
Ishii Y; Takami A; Tsuruda K; Kurogi A; Yamada H; Oguri K
Drug Metab Dispos; 1997 Feb; 25(2):163-7. PubMed ID: 9029046
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.
Li L; Deng G; Tang Y; Mao Q
PLoS One; 2015; 10(5):e0126263. PubMed ID: 25993113
[TBL] [Abstract][Full Text] [Related]
37. UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.
Meza-Junco J; Chu QS; Christensen O; Rajagopalan P; Das S; Stefanyschyn R; Sawyer MB
Cancer Chemother Pharmacol; 2009 Dec; 65(1):1-4. PubMed ID: 19672597
[TBL] [Abstract][Full Text] [Related]
38. Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome.
Gailite L; Rots D; Pukite I; Cernevska G; Kreile M
BMC Pediatr; 2018 Oct; 18(1):317. PubMed ID: 30285761
[TBL] [Abstract][Full Text] [Related]
39. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats.
Jia Z; Dankó I
Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256
[TBL] [Abstract][Full Text] [Related]
40. Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus.
Fujiwara R; Nguyen N; Chen S; Tukey RH
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5024-9. PubMed ID: 20194756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
